TAG:
cap
Good Market Analysis Leads to Accurate Predictions
By R. Lewis Dark | From the Volume VI No. 3 – February 22, 1999 Issue
HOW MANY OF YOU REMEMBER WHEN, JUST A FEW YEARS AGO, it was MetPath/Corning Clinical Laboratories (CCL) which was on the financial ropes? At that time, SmithKline Beecham, PLC was expected to be the likely purchaser of CCL. The date was January 31, 1996. The Wall Street Journal…
Quest to Pay $1.27 Billion To Buy SB’s Lab Division
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Consolidation is the story of the clinical laboratory industry during the 1990s. The decade will close out with the granddaddy laboratory consolidation of them all! When Quest Diagnostics Incorporated completes its acquisition of SmithKline Beecham Clinical Laboratories later…
Integrating Quest & SBCL Presents a Big Challenge
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Will lessons learned during the commercial lab industry’s consolidation frenzy be learned and applied in the Quest-SBCL merger? History has a way of repeating itself. But Quest Diagnostics’ CEO has a different plan. He also has a tool not utilized by lab executives earlie…
Successful Laboratories Share Winning Methods
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Leading laboratory organizations from three countries will take the podium at the EXECUTIVE WAR COLLEGE in New Orleans on May 11-12, 1999. Their objective: to share up-to-date information on effective laboratory management strategies and methods used to deal with the challeng…
Pathology Consolidation Offers Many Local Benefits
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Consolidation of pathology practices can be a complex and drawn-out process. But it doesn’t have to be that way. During the 1990s, Bayless Pathmark of Cleveland grew from a two-man practice into a regional pathology resource numbering 22 pathologists and serving 10 hospital…
Bio-Reference Labs, Tenet Healthcare, IMPATH
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
BIO-REFERENCE LABS QUIETLY IMPROVING LAB INFORMATION CAPABILITY LABORATORY INFORMATION is the strategic business plan driver at Bio-Reference Laboratories, Inc. of Elmwood Park, New Jersey. The company has begun to install an information management system throughout its labo…
Automated Pap Smear Screening Expected to Build Market Share
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
EXPECT 1999 TO BE A PIVOTAL YEAR in automated Pap smear screening. This new technology is now poised to enter general clinical usage. As it does, an increasing volume of clinical data will make the case: either automated screening of Pap smears is clinically effective and economically justified—or…
“February 22, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
Here’s more validation that laboratories can use information links to doctors’ offices as added value. A recent survey of hospital CIOs was completed by PriceWaterHouseCoopers, Zinn Enterprises and Modern Healthcare Weekly. It revealed that the number on…
“Value Added†Services Essential to Success
By R. Lewis Dark | From the Volume VI No. 2 – February 1, 1999 Issue
ONE ELEMENT COMMON TO SUCCESSFUL LABORATORY ORGANIZATIONS of the future will be the ability to both understand the concept of “value added†services and to offer such services to customers. At its core, value added is an essential business strategy. There are many ways to define “value added.â…
IMPATH Creates Its Brand Of Value-Added Pathology
By Robert Michel | From the Volume VI No. 2 – February 1, 1999 Issue
CEO SUMMARY: IMPATH Inc. is a pathology company with an interesting twist. It doesn’t compete directly with community hospital-based pathologists like some national AP providers. Instead, it offers AP services which supplement the capabilities of the local pathologist. The formula must …
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized